Publications by authors named "Andrew Nelsen"

Claim this Profile
R
Real-world use of initial combination treatment in the management of pulmonary arterial hypertension.
Sandeep Sahay, Megan Sisk, Andrew Nelsen, Benjamin Wu, John Ryan

Ther Adv Respir Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Evaluation of the Pulmonary Hypertension Functional Classification Self-Report (PH-FC-SR) Measurement Properties: A Patient-Focused Measure.
Rebecca Crawford, Lori McLeod, Stuart Yarr, Ross Morrison, Benjamin Wu, Andrew C Nelsen

Chest· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV.
Raymond L Benza, Mardi Gomberg-Maitland, Harrison W Farber, Carmine Dario Vizza, Meredith Broderick, Andrew C Nelsen

J Heart Lung Transplant· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting.
Vijay P Balasubramanian, Zeenat Safdar, Margaret R Sketch, Meredith Broderick, Andrew C Nelsen

Pulm Circ· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.
Steven D Nathan, Aaron Waxman, Sudarshan Rajagopal, Amy Case, Shilpa Johri, Andrew Nelsen

Lancet Respir Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily.
Shelley Shapiro, Stacy Mandras, Ricardo Restrepo-Jaramillo, Eric Shen, Meredith Broderick, Andrew C Nelsen

Pulm Circ· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapy in Pulmonary Arterial Hypertension-Targeting the Nitric Oxide and Prostacyclin Pathways.
Stacy Mandras, Gabor Kovacs, Horst Olschewski, Meredith Broderick, Andrew Nelsen

J Cardiovasc Pharmacol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Pulmonary Hypertension Functional Classification Self-Report: a patient version adapted from the World Health Organization Functional Classification measure.
Kristin B Highland, Rebecca Crawford, Peter Classi, Ross Morrison, Lynda Doward, Andrew C Nelsen

Health Qual Life Outcomes· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary hypertension due to interstitial lung disease or chronic obstructive pulmonary disease: a patient experience study of symptoms and their impact on quality of life.
Hilary M DuBrock, Steven D Nathan, Bryce B Reeve, Nicholas A Kolaitis, Stephen C Mathai, Andrew C Nelsen

Pulm Circ· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of inhaled treprostinil on risk stratification with noninvasive parameters: a post hoc analysis of the TRIUMPH and BEAT studies.
Adriano R Tonelli, Sandeep Sahay, Kathryn W Gordon, Lisa D Edwards, Andrew G Allmon, Andrew C Nelsen

Pulm Circ· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel dose-response analyses of treprostinil in pulmonary arterial hypertension and its effects on six-minute walk distance and hospitalizations.
Gautam Ramani, Steven Cassady, Eric Shen, Meredith Broderick, Allie Wasik, Andrew Nelsen

Pulm Circ· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study.
Bonnie B Dean, Vishal Saundankar, Dana Stafkey-Mailey, Rebekah H Anguiano, Andrew C Nelsen

Drugs Real World Outcomes· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study.
Bonnie B Dean, Vishal Saundankar, Dana Stafkey-Mailey, Rebekah H Anguiano, Andrew C Nelsen

Drugs Real World Outcomes· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implantable system for treprostinil: a real-world patient experience study.
Shelley Shapiro, Robert C Bourge, Patti Pozella, David F Harris, Erick H Borg, Andrew C Nelsen

Pulm Circ· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bronchodilation induced by PGE is impaired in Group III pulmonary hypertension.
Gulsev Ozen, Chabha Benyahia, Salma Mani, Kamel Boukais, Adam M Silverstein, Andrew C Nelsen

Br J Pharmacol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Patients with Pulmonary Arterial Hypertension Using Administrative Claims Algorithms.
Stephen C Mathai, Anna Ryan Hemnes, Scott Manaker, Rebekah H Anguiano, Bonnie B Dean, Andrew C Nelsen

Ann Am Thorac Soc· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of delayed treatment on 6-minute walk distance test in patients with pulmonary arterial hypertension: A meta-analysis.
Carmine Dario Vizza, Roberto Badagliacca, Chad R Messick, Youlan Rao, Andrew C Nelsen

Int J Cardiol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing characteristics of oral treprostinil in real-world clinical practice.
Vijay P Balasubramanian, Chad R Messick, Meredith Broderick, Andrew C Nelsen

Pulm Circ· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comprehensive Review of Treprostinil Pharmacokinetics via Four Routes of Administration.
Parag Kumar, Emily Thudium, Kevin Laliberte, David Zaccardelli, Andrew Nelsen

Clin Pharmacokinet· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistency of return to normal function, productivity, and satisfaction following migraine attacks treated with sumatriptan/naproxen sodium combination.
Stephen H Landy, Roger K Cady, Andrew Nelsen, Jonathan White, M Chris Runken

Headache· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension.
Hubert Chen, Erika B Rosenzweig, S Karl Gotzkowsky, Carl Arneson, Andrew C Nelsen

Health Qual Life Outcomes· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid transition from inhaled iloprost to inhaled treprostinil in patients with pulmonary arterial hypertension.
Robert C Bourge, Victor F Tapson, Zeenat Safdar, Raymond L Benza, Richard N Channick, Andrew C Nelsen

Cardiovasc Ther· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution HLA genotyping and severe cutaneous adverse reactions in lamotrigine-treated patients.
Gbenga R Kazeem, Charles Cox, Jennifer Aponte, John Messenheimer, Celia Brazell, Andrew C Nelsen

Pharmacogenet Genomics· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medullary pain facilitating neurons mediate allodynia in headache-related pain.
Rebecca M Edelmayer, Todd W Vanderah, Lisa Majuta, En-Tan Zhang, Beatriz Fioravanti, Andrew C Nelsen

Ann Neurol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of CYP3A5 genotype on dexamethasone induction of CYP3A activity in African Americans.
Patrick J Roberts, Kristan D Rollins, Angela D M Kashuba, Mary F Paine, Andrew C Nelsen

Drug Metab Dispos· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis